Trump paused plans for 100 tariffs on imported drugs after striking a $70 billion deal with Pfizer. The agreement expands U.S. manufacturing and launches TrumpRx.gov in exchange for a three-year tariff reprieve. The White House said other drugmakers must join or face duties, as analysts noted Trump’s hardball negotiating style.